Panchkula, Feb.12, 2026:- Alchemist Ojas Hospital, Panchkula on Thursday announced the successfully performing 50 transcatheter aortic valve replacement (TAVR) procedures. The accomplishment highlights the hospital's growing expertise in advanced structural heart interventions and its commitment to delivering world-class cardiac care.
TAVR is a minimally invasive, life-saving procedure used to treat severe aortic stenosis, particularly in elderly and high-risk patients who are not ideal candidates for open-heart surgery. The procedure allows for quicker recovery, shorter hospital stays, and significantly improved quality of life.
Addressing a press conference here today, Dr. Rajat Datta, director-department of interventional cardiology at Ojas Hospital, Panchkula, a unit of Alchemist Hospitals, Panchkula said that TAVR has revolutionized the treatment of aortic valve disease, especially for elderly and high-risk patients.
Dr. Rohit Parti, director-department of interventional cardiology at Alchemist Hospital, Panchkula said that with advanced cath lab infrastructure and clinical expertise, we continue to expand access to complex cardiac interventions in the region.
TAVR offers new hope to patients who previously had limited treatment options. The procedure significantly reduces procedural risk while ensuring faster recovery and improved functional status, stated Dr. Devendra Singh Bisht, senior consultant- interventional cardiologist & electro-physiologist.
Dr. Manish Vinayak, senior consultant-interventional cardiology said that our focus has always been on patient safety, precision, and long-term outcomes. Every TAVR case is carefully evaluated by our heart team to ensure personalized treatment planning.
No comments:
Post a Comment